Status:
COMPLETED
Study on the Response to Tetanus Vaccination of People Living With HIV
Lead Sponsor:
Centre Hospitalier de Niort
Conditions:
HIV Infections
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The response to primary tetanus immunization of HIV-infected children is lower than that of uninfected children. Response to tetanus toxoid (TT) booster doses in adults living with HIV who have recei...
Eligibility Criteria
Inclusion
- Person aged ≥ 18 years
- Person infected with HIV followed in the infectious diseases department of CH Niort
- Born in France
- Affiliate or beneficiary of a social security scheme
- Being able to give free and informed consent to participation in research
Exclusion
- Persons with a contraindication to tetanus vaccination
- Persons under guardianship or curatorship or without civil law
Key Trial Info
Start Date :
March 11 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 24 2020
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT03853681
Start Date
March 11 2019
End Date
February 24 2020
Last Update
October 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier de Niort
Niort, France, 79000